Overview
Sequential, a genomic testing company specializing in non-invasive human clinical samples, has raised $3.5 million in its first equity funding round, increasing its total funding to $7.5 million. This funding aims to enhance its AI-powered discovery platform for skin microbiome testing, addressing challenges in genomic analysis. Key investors were not specified.
Products
Loading...
Recent Deals
Sequential: $3.5 Million Raised By Skin Microbiome Testing Company For AI-Powered Discovery PlatformSequential, a genomic testing company specializing in non-invasive human clinical samples, has raised $3.5 million in its first equity funding round, increasing its total funding to $7.5 million. This funding aims to enhance its AI-powered discovery platform for skin microbiome testing, addressing challenges in genomic analysis. Key investors were not specified.